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A diverse array of neuromodulators governs cellular
function in the prefrontal cortex (PFC) via the activa-
tion of G-protein-coupled receptors (GPCRs). How-
ever, these functionally diverse signals are carried
and amplified by a relatively small assortment of
intracellular second messengers. Here, we examine
whether two distinct Gai-coupled neuromodulators
(norepinephrine and GABA) act as redundant regu-
lators of glutamatergic synaptic transmission. Our
results reveal that, within single dendritic spines of
layer 5 pyramidal neurons, alpha-2 adrenergic recep-
tors (a2Rs) selectively inhibit excitatory transmission
mediated by AMPA-type glutamate receptors, while
type B GABA receptors (GABABRs) inhibit NMDA-
type receptors. We show that both modulators act
via the downregulation of cAMP and PKA. However,
by restricting the lifetime of active Gai, RGS4 pro-
motes the independent control of these two distinct
target proteins. Our findings highlight a mechanism
by which neuromodulatory microdomains can be
established in subcellular compartments such as
dendritic spines.
INTRODUCTION
Neuromodulation via G protein-coupled receptors (GPCRs) pro-
vides a ubiquitous mechanism for regulating neuronal activity in
the mammalian brain. In contrast to classical neurotransmitters
that directly excite or inhibit postsynaptic neurons, neuromodu-
lators alter neuronal excitability and modify synaptic transmis-
sion (Destexhe et al., 1994; Dismukes, 1979). Interestingly, there
is a paradoxical mismatch between the diversity of modulatory
ligands and the relative paucity of GPCR-linked second
messenger systems such as adenylate cyclase and phospholi-
pase C. The mobility of dissociated G protein subunits and
downstream molecules such as calcium (Ca2+), cAMP, and
inositol-1,4,5-triphosphate should further reduce the cellular
capacity for segregated signaling pathways. Nevertheless, there
is evidence for the functional compartmentalization of soluble
messengers into independent microdomains, which could
contribute to neuromodulatory specificity. For example, rapid326 Cell Reports 12, 326–334, July 14, 2015 ª2015 The Authorsintracellular buffering coupled with potent extrusion mecha-
nisms spatially restricts Ca2+ within presynaptic terminals and
dendritic spines (Higley and Sabatini, 2008; Lisman et al.,
2007; Yuste et al., 2000). However, the potential for mobile,
non-ionic signaling molecules to be isolated within synaptic
microdomains is largely unknown.
In the prefrontal cortex (PFC), neuromodulation by both
norepinephrine (NE) and gamma-amino butyric acid (GABA) reg-
ulates higher cognitive functions, including attention and short-
term ‘‘working’’ memory (Gamo and Arnsten, 2011; Kesner and
Churchwell, 2011). Altered levels of NE andGABA are also linked
to neuropsychiatric disorders, such as schizophrenia, attention
deficit, and addiction (Arnsten, 2011; Stan and Lewis, 2012;
Tyacke et al., 2010). Experimental evidence suggests that both
type 2 alpha adrenergic receptors (a2Rs) and type B GABA re-
ceptors (GABABRs) modulate excitatory glutamatergic signaling
in the PFC (Chalifoux and Carter, 2010; Ji et al., 2008; Liu et al.,
2006). Additionally, ultrastructural studies have localized both
a2Rs and GABABRs to dendritic spines, the location of synaptic
glutamate receptors (Kulik et al., 2003; Wang et al., 2007). Both
a2Rs and GABABRs are GPCRs coupled to the G protein subunit
Gai, whose activation leads to the inhibition of adenylate cyclase
and decreased production of cAMP (Knight and Bowery, 1996;
Summers and McMartin, 1993). The subsequent reduction in
cAMP-dependent protein kinase (PKA) activity provides a poten-
tial mechanism for the control of both AMPA- and NMDA-type
glutamate receptors (AMPARs and NMDARs, respectively)
(Chen et al., 2008; Esteban et al., 2003; Raymond et al., 1994).
These observations raise the question of whether a2Rs and
GABABRs act as redundant modulators of prefrontal synaptic
transmission.
To test this hypothesis, we combined electrophysiological
recordings and two-photon imaging of PFC pyramidal neurons
with optical stimulation of excitatory glutamatergic synapses
using focal glutamate uncaging (Carter and Sabatini, 2004).
Our results reveal the surprising observation that activating
a2Rs reduces AMPAR-mediated responses, whereas activating
GABABRs decreases NMDAR-mediated responses. Notably,
both modulatory pathways utilize Gai-mediated downregulation
of cAMP and PKA signaling, and this dissociation occurs despite
functional evidence that both a2Rs and GABABRs are located in
the same dendritic spines. We further find that inhibiting the
GTPase activating protein RGS4 eliminates the selective
compartmentalization of adrenergic and GABAergic actions.
Thus, RGS4 promotes the independent control of two distinct
Figure 1. a2Rs and GABABRs Differentially
Modulate AMPA- and NMDA-type Gluta-
mate Receptors
(A) (i) Two-photon image of a layer 5 pyramidal
neuron filled with Alexa Fluor 594 dye via the patch
pipette. White box indicates the basal dendritic
arbor. (ii) Close-up image of a dendritic spine.
Asterisk shows the location of glutamate uncag-
ing. (iii) Fluorescence collected in a line scan indi-
cated on (ii) by dashed line. Arrowhead shows the
time point of glutamate uncaging.
(B) (i) Mean AMPAR-mediated uEPSCs in control
(black) and guanfacine (red) ±SEM (shaded
areas). (ii) AMPAR-mediated uEPSCs in control
(black) and baclofen (blue) ±SEM (shaded areas).
(iii) Bars represent mean uEPSC amplitudes in
control (gray), guanfacine (red), and baclofen
(blue) ±SEM.
(C and D) (Ci) 2PLU-evoked NMDAR-currents
and (Di) Ca2+ transients in control (black) and
guanfacine (red), mean (solid lines) ±SEM (shaded
areas). (Cii) NMDAR-mediated uEPSCs and (Dii)
Ca2+ transients in control (black) and baclofen
(blue) ±SEM (shaded areas). (Ciii) Bars represent
mean uEPSC amplitudes in control (gray), guan-
facine (red), and baclofen (blue) ±SEM (Diii).
Mean amplitude of NMDAR Ca2+ transients in
control (gray), guanfacine (red), and baclofen (blue)
±SEM. *p < 0.05, unpaired t test.target proteins by eliminating crosstalk between signaling path-
ways in dendritic spines. Our results highlight a novel mecha-
nism by which biochemical multiplexing can occur in subcellular
microdomains.
RESULTS
Distinct Gai-Coupled Agonists Differentially Modulate
Postsynaptic Glutamate Receptors
We investigated whether two distinct neuromodulators that
target the same biochemical pathway produce similar changes
in glutamatergic transmission. To identify the actions of a2Rs
and GABABRs on postsynaptic glutamatergic signaling, we
used two-photon laser uncaging of glutamate (2PLU) to stimu-
late single excitatory synapses on prefrontal L5 pyramidal neu-
rons while recording excitatory postsynaptic currents (uEPSCs)
and imaging postsynaptic calcium (Ca2+) signals. Uncaging
power was individually calibrated for spines on the proximal
basal dendrites (<100 mm from the soma) to emulate endoge-
nous glutamate release from a single presynaptic terminal (Fig-
ures 1A and S1).
First, we pharmacologically isolated AMPAR-mediated
responses and recorded synaptic currents (Figure 1B; see
Experimental Procedures). Bath application of the a2R agonist
guanfacine (40 mM) reduced uEPSCs from 17.2 ± 0.9 pA (n =
32 spines) to 8.8 ± 0.7 pA (n = 32 spines, p < 0.0001, unpaired
t test). In contrast, the GABABR agonist baclofen (5 mM) had no
effect on AMPAR-mediated uEPSC amplitude (16.9 ± 1.0 pA,n = 26 spines versus 16.9 ± 1.1 pA, n = 30 spines, p = 0.97).
We then performed converse experiments in which we isolated
NMDAR-mediated responses and recorded both uEPSCs
and DCa2+ in the spine head (Figures 1C and 1D; see Supple-
mental Experimental Procedures). Under these conditions,
2PLU-evoked DCa2+ is mediated by influx through NMDARs
(Figure S2). Guanfacine had no effect on either uEPSC amplitude
(24.1 ± 3.1 pA, n = 38 spines, versus 26.6 ± 2.9 pA, n = 32 spines,
p = 0.56) or DCa2+ (0.71 ± 0.035 DG/Gsat versus 0.64 ± 0.034
DG/Gsat, p = 0.17). In contrast, baclofen significantly reduced
NMDAR-mediated DCa2+ in the spine head (0.68 ± 0.03DG/Gsat,
n = 33 spines versus 0.49 ± 0.02 DG/Gsat, n = 35 spines, p <
0.0001) but did not alter uEPSCs (24.3 ± 2.5 pA, versus 23.2 ±
2.0 pA, p = 0.73). Thus, our results demonstrate that a2Rs and
GABABRs selectively modulate postsynaptic AMPARs and
NMDARs, respectively.
Modulation of AMPARs and NMDARs Is Mediated by
Downregulation of PKA
One explanation for our results is that adrenergic andGABAergic
modulation of glutamate receptors occurs via distinct biochem-
ical signaling pathways.We therefore isolated AMPAR-mediated
synaptic responses and tested the ability of H89 (10 mM), a selec-
tive blocker of cAMP-dependent kinase (PKA), to mimic and
occlude the actions of guanfacine. In the presence of H89,
uEPSC amplitude was 12.4 ± 1.3 pA (n = 30 spines, Figures 2A
and 2B). In the combined presence of H89 and guanfacine,
uEPSC amplitude was 9.0 ± 0.6 pA (n = 35 spines, Figures 2ACell Reports 12, 326–334, July 14, 2015 ª2015 The Authors 327
Figure 2. Both a2R Modulation of AMPARs
and GABABR Modulation of NMDARs Are
Mediated by Downregulation of PKA
(A) AMPAR-mediated uEPSCs. Solid black lines
show mean ± SEM (dark gray shading) for
responses in the PKA antagonist H89 (10 mM),
H89 + guanfacine (40 mM), the PKA activator
N-6-benzo-cAMP (bcAMP, 100 mM), or bcAMP +
guanfacine (left to right). Light gray and red shaded
areas represent mean ± SEM of control and
guanfacine groups, respectively, for comparison.
(B) Bars represent mean amplitudes ±SEM of
uEPSC under the above conditions.
(C) NMDAR-mediated uEPSCs. Solid black lines
show mean ± SEM (dark gray shading) for re-
sponses in the PKA antagonist H89 (10 mM), H89 +
baclofen (5 mM), the PKA activator bcAMP
(100 mM), or bcAMP + baclofen (left to right). Light
gray and blue shaded areas represent mean ±
SEM of control and baclofen groups, respectively,
for comparison.
(D) 2PLU-evoked Ca2+ transients under the same
conditions as in (C).
(E and F) Bars represent mean amplitudes ±SEM
of uEPSC (E) and Ca2+ transients under the above
conditions (F).
*p < 0.05, Tukey’s multiple comparison test.and 2B). We also examined the actions of the selective PKA acti-
vator and cAMP analog N6-benzo-cAMP (bcAMP, 100 mM). In
the presence of bcAMP, uEPSC amplitude was 19.1 ± 1.7 pA
(n = 30 spines). Combined application of bcAMP and guanfacine
produced a uEPSC amplitude of 17.0 ± 1.5 pA (n = 31 spines). A
one-way ANOVA comparing all groups revealed significant dif-
ferences (F = 19.57, p < 0.0001) that we explored using post
hoc comparisons (significant for p < 0.05, Tukey’s test). These
analyses revealed that H89 both mimicked and occluded the
actions of guanfacine, whereas bcAMP blocked the actions of
guanfacine (Figures 2A and 2B).
In a parallel set of studies, we isolated NMDARs and examined
the biochemical mechanisms underlying their modulation by
baclofen. In the presence of H89, the NMDAR-mediated uEPSC
was 14.8 ± 1.8 pA (n = 29 spines) and the DCa2+ was 0.37 ± 0.03
DG/Gsat. Co-application of H89 and baclofen yielded a uEPSC of
15.3 ± 1.9 pA (n = 29 spines) and a DCa2+ of 0.36 ± 0.02 DG/Gsat.
After bcAMP, the uEPSC was 21.0 ± 1.6 pA and DCa2+ was
0.61 ± 0.03 DG/Gsat (n = 30 spines), while combined bcAMP
and baclofen produced a uEPSC of 28.0 ± 2.8 pA and a DCa2+
of 0.59 ± 0.02 DG/Gsat (n = 31 spines, Figures 2C–2F). As above,
Tukey’s post hoc tests (ANOVA, F = 43.48, p < 0.0001) revealed
that H89 occluded and bcAMP blocked the actions of baclofen
on NMDAR-mediated responses (Figures 2C–2F).
Our data indicate that both a2Rs and GABABRs exert control
of glutamate receptors via a downregulation of PKA signaling.
Phosphorylation of the Serine 845 (S845) residue of the GluA1
subunit is known to regulate AMPA-receptor stability and mem-
brane trafficking (Esteban et al., 2003). We therefore probed
whether guanfacine or baclofen altered S845 phosphorylation.328 Cell Reports 12, 326–334, July 14, 2015 ª2015 The AuthorsAssays were performed on four to six independent samples,
and one-way ANOVA revealed significant effects (F = 19.81,
p < 0.0001) that were investigated with post hoc analyses
(Figures 3A and 3B). In comparison to untreated PFC tissue,
10-min incubation with either guanfacine or H89 significantly
reduced S845 phosphorylation, while baclofen had no effect.
In addition, the adenylate cyclase activator forskolin (50 mM)
significantly increased the phosphorylation of AMPARs relative
to control.
A recent study identified a novel PKA phosphorylation site on
the GluN2B subunit, Serine 1166 (S1166), which modulates the
Ca2+ permeability of NMDARs (Murphy et al., 2014). In keeping
with our Ca2+ imaging data, we found that application of either
baclofen or H89, but not guanfacine, reduced S1166 phosphor-
ylation. Conversely, forskolin enhanced the phosphorylation of
the same residue (Figures 3C and 3D, one-way ANOVA, F =
20.48, p < 0.0001, Tukey’s post hoc test). These results suggest
the involvement of S1166 in the GABAergic regulation of Ca2+
influx through NMDARs, thoughwe cannot rule out the participa-
tion of other PKA targets.
To confirm that functional GluN2B subunits contribute
to 2PLU-evoked NMDAR responses in our recordings, we
measured NMDAR activation in the presence of the specific
GluN2B antagonist ifenprodil (3 mM). Ifenprodil significantly
reduced NMDAR currents (22.7 ± 1.8 pA, n = 46 spines versus
14.0 ± 1.4 pA, n = 33 spines, p = 0.0006, Figures S2C and
S2D) and DCa2+ (0.54 ± 0.02 DG/Gsat, n = 46 spines versus
0.44 ± 0.02 DG/Gsat, n = 33 spines, p = 0.0003, Figure S2).
Thus, baclofen but not guanfacine diminishes synaptic Ca2+
influx through NMDARs via the dephosphorylation of the GluN2B
Figure 3. a2R and GABABR Activation Re-
duces GluA1 (S845) and GluN2B (S1166)
Phosphorylation in the PFC, Respectively
(A) Western blot for phosphorylated GluA1 (S845)
in prefrontal tissue lysates, left to right: under
control (n = 6 animals), guanfacine (40 mM, n = 5
animals), baclofen (5 mM, n = 5 animals), H89
(10 mM, n = 5 animals), or forskolin (50 mM, n = 4
animals) conditions (top). Membranes were then
re-blotted for total GluA1 (bottom).
(B) Quantification of S845 phosphorylation. Bars
show mean ± SEM normalized to control (black) in
guanfacine (red), baclofen (blue), H89 (striped),
and forskolin (green).
(C) Western blots depicting GluN2B (S1166)
phosphorylation (top) and total GluN2B (bottom)
in, left to right: control (n = 5 animals), guanfacine
(40 mM, n = 6 animals), baclofen (5 mM, n = 6 ani-
mals), H89 (10 mM, n = 5 animals), or forskolin
(50 mM, n = 5 animals).
(D) Bars represent mean ± SEM. S1166 phosphor-
ylation in control (black), guanfacine (red), baclofen
(blue), H89 (striped), and forskolin (green).
*p < 0.05, Tukey’s multiple comparison test.subunit at the Serine 1166 residue. In summary, these results
confirm that the surprisingly disparate actions of a2Rs and
GABABRs on glutamate receptors are all mediated by downre-
gulation of PKA signaling.
Adrenergic and GABAergic Actions Are Localized to the
Same Dendritic Spine
As our initial studies compared separate populations of spines in
control and treatment conditions, one explanation for our find-
ings is that either guanfacine or baclofen may act non-cell-
autonomously such that the two PKA-dependent signaling
pathways occur in different cells. To test this possibility, we
co-applied guanfacine and baclofen while stimulating a single
synapse using 2PLU. We monitored both uEPSCs and DCa2+
while voltage clamping the cell at either 70 mV or +40 mV to
measure AMPAR- or NMDAR-mediated responses, respectively
(Figure 4). Compared to baseline, combined application of
guanfacine and baclofen for 10 min decreased AMPAR currents
(18.8 ± 2.8 pA versus 12.1 ± 1.7 pA, n = 6 spines, p = 0.0163,
paired t test, Figure 4A). As above, the drug combination did
not change NMDAR-mediated currents (12.7 ± 2.5 pA versus
15.6 ± 5.1 pA, n = 6 spines, p = 0.9220, paired t test, Figure 4B)
but decreased DCa2+ (0.21 ± 0.04 DG/Gsat versus 0.12 ± 0.03
DG/Gsat, p = 0.0132, paired t tests, Figure 4C). Importantly, the
combined actions of guanfacine and baclofen on AMPAR-medi-
ated currents (n = 6 spines, p = 0.626, paired t test) and NMDAR-
mediated Ca2+ influx (n = 6 spines, p = 0.6555, paired t test) were
occluded by adding the membrane-impermeable PKA antago-
nist PKI(6-22) (20 mM) to the recording pipette (Figures 4A–4C).
These results confirm that the PKA-dependent actions of a2Rs
and GABABRs cell-autonomously modulate both types of gluta-
mate receptors.
Our results might also be explained if a2Rs and GABABRs
are not co-localized, giving rise to a physical segregation of
signaling pathways that could produce a functional dissocia-
tion. To test this possibility, we performed three sets of exper-iments. First, we used a puffer pipette to locally apply a
combination of guanfacine and baclofen to a small dendritic re-
gion while holding the cell at either 70 mV or +40 mV (Figures
5A–5D). This focal drug application yielded similar results to
bath application. AMPAR-mediated currents were decreased
(19.7 ± 2.6 pA to 9.3 ± 1.9 pA, n = 10, p = 0.0083), NMDAR-
mediated currents were not altered (11.4 ± 2.1 pA versus
10.7 ± 2.1 pA, n = 10, p = 0.39), and NMDAR-mediated
DCa2+ was decreased (0.22 ± 0.05 DG/Gsat versus 0.088 ±
0.02 DG/Gsat, n = 10, p = 0.0055).
Second, we performed immunohistochemical triple-staining
to test for co-localization of a2Rs and GABABRs at the post-
synaptic density (Figures 5E and 5F; see Supplemental Experi-
mental Procedures). a2Rs and GABABRs were significantly
more co-localized with the postsynaptic protein PSD95 than
the presynaptic marker bassoon or a pixel-shuffled control.
Third, we tested the actions of a2Rs andGABABRs on voltage-
gated calcium channels (VGCCs), known to be modulated by a
PKA-independent pathway involving the membrane delimited
beta-gamma subunits (Gbg) associated with Gai (Herlitze et al.,
1996; Yan and Surmeier, 1996). We monitored VGCC-depen-
dent DCa2+ in spines and adjacent dendritic shafts evoked by
back-propagating action potentials (bAPs, Figure S3; see Exper-
imental Procedures) (Sabatini and Svoboda, 2000). Under con-
trol conditions, DCa2+ in spines was 0.052 ± 0.003 DG/Gsat
(n = 34 spines). In the presence of either guanfacine or baclofen,
DCa2+ was 0.029 ± 0.002 DG/Gsat (n = 38 spines) or 0.031 ±
0.001 DG/Gsat (n = 41 spines), respectively. Combined applica-
tion of guanfacine and baclofen produced a DCa2+ of 0.036 ±
0.003 DG/Gsat (n = 33 spines, Figures S3B–S3E). One-way
ANOVA (F = 20.52, p < 0.0001) with post hoc testing revealed
that both guanfacine and baclofen significantly reduced DCa2+,
but there was no additional effect of combining the two drugs.
Similar results were seen for DCa2+ in the corresponding den-
dritic shafts. These results indicate modulation of physically
overlapping pools of VGCCs. Thus, the combination of findingsCell Reports 12, 326–334, July 14, 2015 ª2015 The Authors 329
Figure 4. a2Rs and GABABRs Cell Autono-
mously Modulate Glutamate Receptors
(Ai and Bi) (Ai) Mean ± SEM traces (solid lines and
shaded areas, respectively) of 2PLU-evoked
uEPSCs from a single spine with the cell voltage
clamped at 70 mV or at (Bi) +40 mV to measure
AMPAR- and NMDAR-mediated currents,
respectively. Black traces are uEPSCs during
baseline recording, magenta traces show currents
following 10 min exposure to guanfacine plus
baclofen (n = 6 spines on six cells).
(Ci) Mean ± SEM traces (solid lines and shaded
areas, respectively) showing DCa2+ traces with the
cell voltage clamped at +40 mV during baseline
(black) and after guanfacine plus baclofen flow in
(magenta).
(Aii–Cii) Same experiment as in (Ai)–(Ci), but with
the membrane-impermeable PKA inhibitor
PKI(6-22) (20 mM) in the recording pipette (n = 6
spines on six cells).
(Aiii and Biii) Mean ± SEM uEPSC amplitudes
(bars) and for each individual cell (lines) recorded
at70 or +40 mV holding potential during baseline
(gray) and post guanfacine and baclofen (magenta)
using control- or PKI(6-22)-containing pipette
solution.
(Ciii) As above for NMDAR-mediated Ca2+
transients.
*p < 0.05, paired t test.strongly supports the conclusion that a2Rs and GABABRs are
co-localized in the same dendritic spines.
Preferential Structural Co-localization of GPCRs with
Glutamate Receptors
Our results indicate functional coupling of a2Rs with AMPARs
and GABABRs with NMDARs. To determine whether these re-
ceptor groupings have a structural underpinning, we performed
a proximity ligation assay that identifies proteins localized within
10–15 nm from each other (So¨derberg et al., 2006). Co-staining
for GluA1 and a2R produced significantly higher labeling density
than for GluA1 and GABABR (1.7 ± 0.2 versus 0.9 ± 0.1 puncta
per 100 mm2, n = 31 images from three mice, p = 0.0004). Simi-
larly, co-staining for NR1 and GABABR produced significantly
higher labeling density than for NR1 and a2R (1.2 ± 0.09 versus
0.76 ± 0.08 puncta per 100 mm2, n = 31 images from three mice,
p = 0.0004, Figure 6). This preferential structural localization of
a2Rs/AMPARs and GABABRs/NMDARs at synapses suggests
the existence of synaptic microdomains where neuromodulation
can occur independently despite utilization of similar biochem-
ical signaling pathways.
RGS4 Limits the Crosstalk between Different
Gai-Coupled Receptors
Our results suggest the surprising conclusion that separate,
parallel modulation of glutamate receptors occurs without
biochemical crosstalk in single spines. Notably, although activa-
tion of Gi/o-coupled receptors decreases the amount of cAMP
and active PKA in the spine, the concentration of the active mo-
bile Gai subunit is increased. Thus, some mechanism must limit330 Cell Reports 12, 326–334, July 14, 2015 ª2015 The Authorsthe functional mobility of Gai to prevent signaling crosstalk. One
suchmechanismmight involve Regulators of G protein Signaling
(RGS) proteins that accelerate hydrolysis of GTP to GDP, has-
tening the self-inactivation of Gai (Arshavsky and Pugh, 1998;
Watson et al., 1996; Zhong et al., 2003). To test this possibility,
we measured 2PLU-evoked synaptic currents and correspond-
ing Ca2+ transients in the presence of a selective small molecule
inhibitor (CCG50014; Blazer et al., 2011; Turner et al., 2012) that
targets RGS4, the most abundant RGS family member in layer 5
pyramidal neurons of the PFC (Ebert et al., 2006; Gold et al.,
1997).
CCG50014 (5 mM) by itself did not alter responsesmediated by
either NMDARs or AMPARs (Figures 7A–7C). However, in
contrast to our earlier findings, in the presence of CCG50014,
baclofen produced a significant reduction in AMPAR-mediated
currents (17.5 ± 1.6 pA, n = 31 spines versus 10.0 ± 1.1 pA,
n = 32 spines, p < 0.001). Guanfacine also reduced AMPAR-
mediated currents (to 9.7 ± 0.8 pA, n = 30 spines, p < 0.001) simi-
larly to guanfacine alone (p > 0.05) (Figure 7A). Conversely, in the
presence of CCG50014, guanfacine produced a significant
reduction in NMDAR-mediated currents (27.6 ± 2.8 pA, n = 30
spines versus 15.4 ± 2.4, n = 32 spines, p < 0.01) and DCa2+
(0.68 ± 0.03 DG/Gsat versus 0.5 ± 0.03 DG/Gsat, p < 0.001, Fig-
ures 7B and 7C). Notably, in combination with CCG50014,
baclofen also reduced NMDAR-mediated currents (to 7.8 ±
1.2 pA, n = 35 spines, p < 0.001; Figures 7A and 7C) and
DCa2+ (to 0.37 ± 0.03 DG/Gsat in CCG50014+baclofen, p <
0.001; Figures 7B and 7C).
To confirm the specificity of our results, we dialyzed neurons
with an antibody against RGS4 via the patch pipette, a method
Figure 5. a2Rs and GABABRs Are in the
Same Dendritic Spine
(A) Two-photon image of a L5 pyramidal neuron
(red) and two-photon differential interference
contrast (DIC) image (gray) showing the puffer
pipette near the recorded denritic spine (arrow).
White arrowhead is pointing in the direction of
ACSF flow in the chamber.
(Bi–Di) (Bi) Mean ± SEM uEPSC traces (solid lines
and shaded areas, respectively) of 2PLU-evoked
uEPSCs from a single spine with the cell voltage
clamped at 70 mV or at (Ci and Di) +40 mV
to measure AMPAR- and NMDAR-mediated cur-
rents and Ca2+ influx, respectively. Black traces
are uEPSCs during baseline recording, magenta
traces show currents following 10 min exposure to
locally applied guanfacine plus baclofen (n = 10
spines on ten cells).
(Aii–Cii) uEPSC and Ca2+ transient amplitudes:
mean ± SEM (bars) and for each individual cell
separately (lines) recorded at 70 or +40 mV
holding potential during baseline (gray) and post-
guanfacine and baclofen (magenta).
(Ei) Representative confocal images of PSD95
(green), a2R (red), and GABABR (blue) co-staining.
White arrows point to both GPCRs co-localizing
with PSD95.
(Eii) Bars showing average co-localization of both
a2Rs andGABABRswithPSD95 (green) orBassoon
(black) in original or pixel-shifted (gray) images.previously shown to specifically inhibit RGS4 function (Liu et al.,
2006), and performed similar experiments (Figure S4). We found
that, with the RGS4 antibody in the pipette solution, baclofen
significantly reduced AMPAR-mediated currents (21.1 ±
1.6 pA, n = 30 spines versus 14.14 ± 0.98 pA, n = 32 spines,
p = 0.0003). In complementary experiments, in the presence of
the RGS4 antibody, guanfacine reduced NMDAR-mediated cur-
rents (20.7 ± 2 pA, n = 31 spines versus 7.15 ± 1.3 pA, n = 34
spines, p < 0.0001) and DCa2+ (0.633 ± 0.017 DG/Gsat versus
0.34 ± 0.02DG/Gsat, p < 0.0001). In conclusion, our data indicate
that RGS4 prevents crosstalk between biochemical signaling
cascades and preserves neuromodulatory specificity.
DISCUSSION
Multiple neuromodulatory systems coupled to GPCRs share
common signal transduction pathways. In the prefrontal cortex,
neuronal activity is regulated by Gai-mediated signaling through
receptors for norepinephrine, GABA, dopamine (D2), and acetyl-
choline (M2, M4). However, it remains largely unknown how indi-
vidual neurons distinguish between these modulatory inputs and
prevent crosstalk between similar biochemical signaling path-
ways. Here, we found that activation of a2Rs and GABABRs
selectively inhibits AMPARs and NMDARs, respectively, and
that this modulation occurs at single glutamatergic synapses.
In both cases, the regulation of glutamate receptors occurs via
a Gai-dependent reduction in PKA activity. Our evidence sug-
gests that all four receptors are present in individual spines
with a preferential co-localization (<20 nm) of a2Rs/AMPARs
and GABABRs/NMDARs. Under control conditions, crosstalk
between a2R- and GABABR-coupled signaling cascades is pre-vented by the actions of RGS4, a GTPase Activating Protein
(GAP) that targets Gai (Watson et al., 1996). Our results provide
evidence for a novel mechanism by which biochemical signaling
pathways are functionally compartmentalized and highlight the
role of RGS4 in regulating synaptic transmission (Figure S5). In
future studies, it will be interesting to determine whether other
modulatory pathways (e.g., D2 dopamine receptors) obey similar
compartmentalization to regulate specific glutamate receptors.
Establishment of Synaptic Microdomains for
Neuromodulation
Our data show that, under control conditions, there is no
crosstalk between a2R- and GABABR-mediated modulation of
glutamate receptors despite similar actions on cAMP and PKA
activity. One explanation for this compartmentalization is that
a2Rs and GABABRs are located on different dendritic spines.
We excluded this possibility by (1) showing that AMPAR- and
NMDAR-dependent synaptic responses evoked by stimulation
of a single spine are reduced by focal co-application of guanfa-
cine and baclofen, (2) showing that a2Rs and GABABRs co-
localize with PSD95, and (3) finding that guanfacine and baclofen
mutually occlude each other’s modulation of VGCCs. A second
explanation for our data is that one or both of the actions of guan-
facine and baclofen occur via distinct, non-cell-autonomous
mechanisms. However, we find that loading single cells with a
membrane impermeable PKA antagonist occludes the modula-
tion of both AMPARs and NMDARs, arguing that the relevant
a2Rs and GABABRs are localized to the recorded neuron.
A third possibility is that a2Rs and GABABRs are located in
the same spines, and the lack of crosstalk is mediated by func-
tional compartmentalization of signaling cascades. This latterCell Reports 12, 326–334, July 14, 2015 ª2015 The Authors 331
Figure 6. a2Rs Preferentially Localize near AMPARswhile GABABRs
Preferentially Localize near NMDARs
(A) Representative confocal images from PFC sections after proximity ligation
assay. Tissue was stained with antibodies against the indicated targets. Bright
puncta indicate positive PLA reactions.
(B) Bars indicate mean ± SEM number of puncta per 100 mm2.
Figure 7. Blocking RGS4 Enables Crosstalk between Modulatory
Signaling Pathways
(Ai) AMPAR-mediated currents in the presence of CCG50014 alone (black) or
in combination with guanfacine (red) or baclofen (blue).
(Bi and Ci) (Bi) NMDAR-mediated currents and (Ci) Ca2+ transients in the
presence of the RGS4 inhibitor CCG50014 either alone (black) or in combi-
nation with guanfacine (red) or baclofen (blue). Traces showmean ±SEM (solid
lines and shaded areas, respectively).
(Aii) Mean amplitude ±SEM of AMPAR-mediated currents in control (gray),
guanfacine (pink), and baclofen (light blue), reproduced from Figure 1, or in
CCG50014 (black), CCG50014 with guanfacine (red), and CCG50014 with
baclofen (blue).
(Bii and Cii) Bars represent mean amplitude ±SEM of NMDAR-mediated cur-
rents (Bii) and Ca2+ transients (Cii) in control (gray), guanfacine (pink), and
baclofen (light blue) from Figure 1, or in CCG50014 (black), CCG50014 with
guanfacine (red), and CCG50014 with baclofen (blue).
*p < 0.05, Tukey’s multiple comparison test.conclusion is strongly supported by our results, which suggest a
novel functional microdomain established by the limited lifetime
of Gai, whose signaling is terminated by its endogenous GTPase
activity (Arshavsky and Pugh, 1998). The ability of Gai subunits to
hydrolyze GTP is strongly accelerated by Regulators of G protein
Signaling (RGS) proteins (Watson et al., 1996). Of this protein
family, RGS4 is strongly expressed in layer 5 of the PFC (Ebert
et al., 2006). Here, we show that blocking RGS4 activity pharma-
cologically (CCG50014) or by dialyzing the cells with an antibody
against RGS4 impairs the selectivity of Gai-coupled neuromodu-
lators, thus enabling crosstalk of second messenger systems
and leading to a breakdown in signal specificity in dendritic
spines of layer 5 pyramidal neurons (Figure S8). Notably, previ-
ous computational work explicitly predicted a role for RGS4
in restricting Gai signaling to a small microdomain (Zhong
et al., 2003). In this model, high RGS4 activity can limit diffusion
of GTP-bound Gai to <20 nm. This suggestion is supported
by our proximity ligation assay data, which suggest prefer-
ential postsynaptic coupling of a2Rs/AMPARs and GABABRs/
NMDARs within 20 nm (So¨derberg et al., 2006). There is
mounting anatomical evidence that synaptic proteins, including
glutamate receptors, are organized into 70- to 80-nm clusters
within the postsynaptic density (MacGillavry et al., 2013; Nair
et al., 2013). Precedent for such structural links was shown
previously for a presynaptic b2-adrenergic-AMPAR signaling
complex allowing highly localized cAMP signaling in the hippo-
campus (Joiner et al., 2010). Here, we demonstrate a functional
role for these nano-structures and provide a plausible biochem-
ical mechanism for the segregation of signaling domains within a
single synapse.
We note that an additional explanation for our results is that
both adrenergic and GABAergic activity stimulates an unidenti-
fied non-canonical (e.g., not adenylate cyclase-mediated)
signaling pathway that inhibits cross-modulation of glutamate
receptors. While possible, this explanation seems unlikely given
the findings that two independentmethods of blocking RGS4 ac-332 Cell Reports 12, 326–334, July 14, 2015 ª2015 The Authorstivity lead to cross-modulation. Thus, this alternative explanation
would require the existence of an unidentified GPCR-coupled
pathway that is also regulated by RGS4.
Surprisingly, we find that blocking RGS4 activity allows both
guanfacine and baclofen to modulate the total current through
NMDARs in addition to the Ca2+ influx. A similar result was
seen when blocking PKA signaling directly with H89. This result
suggests a second PKA target on the NMDAR, in addition to
GluN2B S1166, such as GluN1 S897, that controls total current
magnitude. We propose that modest reduction in PKA signaling
(as occurs with activation of GABABRs) influences Ca
2+ influx
by selectively dephosphorylating S1166, while stronger reduc-
tion in PKA signaling (either with a pharmacological block or
the increased activity of Gai following RGS4 block) leads to
decreased Ca2+ and total current by dephosphorylating multiple
targets.
Functionally, our findings suggest that distinct modulatory
systems coupled to PKA signaling differentially impact synaptic
integration. Specifically, adrenergic actions via a2Rs are ex-
pected to reduce electrical summation of inputs leading to a
reduction in neuronal output. In contrast, GABAergic actions
are expected to regulate summation of local dendritic Ca2+ sig-
nals, potentially influencing synaptic plasticity. Thus, breakdown
in the functional segregation of these pathways might lead to
aberrant modulation and dysregulation of cellular activity.
Indeed, mutations in RGS4 have been linked to neuropsychiatric
disorders such as schizophrenia (Levitt et al., 2006). Future
studies are necessary to investigate the interactions of RGS4
and neuromodulatory signaling in disease.
EXPERIMENTAL PROCEDURES
Slice Preparation
All animal handling was performed in accordance with guidelines approved by
the Yale Institutional Animal Care and Use Committee and federal guidelines.
Acute prefrontal cortical (PFC) slices (300 mm) were prepared from wild-type
C57/Bl6 mice (P22-36) and maintained in artificial cerebrospinal fluid (ACSF)
containing (in mM): 126 NaCl, 26 NaHCO3, 1.25 NaH2PO4, 3 KCl, 1 MgCl2,
2 CaCl2, 10 glucose, 0.4 sodium ascorbate, 2 sodium pyruvate, and 3 myo-
inositol, bubbled with 95% O2 and 5% CO2.
Electrophysiology and Imaging
All experiments were conducted at near physiological temperature (32C–
34C). For voltage-clamp recordings, glass electrodes (1.8-3.0 MU) were filled
with internal solution containing (in mM): 135 CsMeSO3, 10 HEPES, 4MgCl2, 4
Na2ATP, 0.4 NaGTP, 10 sodium creatine phosphate, and 0.2% Neurobiotin
(Vector Laboratories), Alexa Fluor-594 (10 mM), Fluo-5F (300 mM), adjusted
to pH 7.3 with CsOH. Electrophysiological recordings were made using a
Multiclamp 700B amplifier, filtered at 4 kHz, and digitized at 10 kHz.
Two-photon imaging was accomplished with a custom-modified Olympus
BX51-WI microscope. Fluorophores were excited using 840 nm light from a
pulsed titanium-sapphire laser and emissions collected by photomultiplier
tubes (Hamamatsu).
For focal stimulation of single dendritic spines,we used two-photon laser un-
caging of glutamate (2PLU). To photorelease glutamate, a second Ti-Sapphire
laser tuned to 720 nm was introduced into the light path using polarization op-
tics. Back propagating action potentials (bAPs) were evoked by injecting brief
current pulses (2 nA, 2 ms) into the cell through the recording pipette.
Data Acquisition and Analysis
Imaging and physiology data were acquired using National Instruments data
acquisition boards and custom software written in MATLAB. Off-line analysis
was performed using custom routines written in MATLAB and IgorPro. Statis-
tical comparisons were conducted in GraphPad Prism 5. Unless otherwise
stated, all data were analyzed using two-tailed, unpaired t tests.
Pharmacology and Reagents
2PLU experiments were performed in normal ACSF supplemented with MNI-
glutamate (2.5 mM) and D-serine (10 mM). To isolate AMPAR-mediated
currents, we added TTX (1 mM), picrotoxin (50 mM), CGP55845 (3 mM), and
CPP (10 mM) to the ACSF. To isolate NMDAR-mediated currents, we modified
our original ACSF to contain 0mMMg and 3mMCa2+ and included TTX (1 mM),
picrotoxin (50 mM), CGP55845 (3 mM), and NBQX 10 mM. In experiments inves-
tigating the effects of baclofen, CGP55845 was omitted from the solutions. For
PKA pharmacology, we applied H89 (10 mM) or N6-benzo-cAMP (100 mM,
Millipore). In some experiments, we included PKI(6-22) (20 mM) in the recording
pipette. To block the actions of RGS4, we added CCG50014 (5 mM). All com-
pounds were from Tocris except where noted.Western Blot Analysis
Brain slices containing the PFC were prepared as described and incubated
with normal ACSF for control or ACSF supplemented with either guanfacine
40 mM, baclofen 5 mM, H89 10 mM, or forskolin 50 mM for 10 min at 32C–
34C before the prefrontal cortex was dissected out, homogenized, and
lysed in 20 mM Tris, 1 mM EDTA and 1 3 Halt protease and phosphatase
inhibitor cocktail and 0.5% SDS (pH 8.0). After centrifugation, samples
were separated by SDS-PAGE and transferred to PVDF membranes. Primary
antibodies against phosphorylated GluA1 S845, phosphorylated GluN2B
S1166 or RGS4 were applied overnight. Bands were visualized using
standard HRP procedures. Membranes were then stripped from antibodies,
re-blocked, and immunoreacted with non-phospho specific anti-GluA1 or
anti-GluN2B primary antibody to establish total amount of GluA1 or GluN2B
in the samples. Scanned autoradiography images were analyzed with Im-
ageJ. Phosphorylation was quantified as phoshorylated/total protein and
normalized to the control values of each experiment.
Immunofluorescence and Proximity Ligation Assay
C57/bl6 mice were transcardially perfused with phosphate buffer (PB) fol-
lowed by 4% paraformaldehyde. To expose synaptic proteins, sections
(70 mm) containing the PFC were permeabilized with 0.1% Triton X-100
and then treated with 0.25 mg/ml pepsin for 10 min at 37C in 0.2 N HCl. Pri-
mary antibodies against PSD95 or Bassoon, a2R, and GABAbR were applied
overnight. Following secondary antibody staining, images were collected
from the PFC region and analyzed in Cell Profiler. Co-localization is given
as the percentage of PSD95 or Bassoon puncta overlapping with both a2R
and GABABR staining.
To perform proximity ligation assay, 70-mm sections containing the PFC
were obtained from theee mice and pepsin treated as described. Glutamate
receptors were co-labeled with GPCRs using primary antibodies against
GluA1 or GluN1 and a2R or GABAbR. Proximity ligation assay (PLA) was
performed using a Duolink In Situ kit (Sigma) in accordance with the manufac-
turer’s instructions. Images were randomly collected from the PFC region of
the sections and analyzed in Cell Profiler.
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